Results for tag: "CKD MBD Drug"

The CKD MBD Drug market is a subset of the pharmaceutical industry focused on drugs used to treat chronic kidney and liver disorders. These drugs are used to manage symptoms, slow the progression of the disease, and reduce the risk of complications. CKD MBD drugs are typically prescribed to patients with chronic kidney and liver diseases, such as chronic kidney disease, end-stage renal disease, and cirrhosis. These drugs are also used to treat acute kidney and liver diseases, such as acute kidney injury and acute liver failure. The CKD MBD Drug market is highly competitive, with a wide range of products available from various manufacturers. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more